Heart failure - symptoms and causes - Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142. Accessed 24 Jul 2023

Redfield MM, Borlaug BA (2023) Heart failure with preserved ejection fraction: a review. JAMA 329:827–838. https://doi.org/10.1001/JAMA.2023.2020

Article  PubMed  Google Scholar 

Kittleson MM, Panjrath GS, Amancherla K et al (2023) 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 81:1835–1878. https://doi.org/10.1016/J.JACC.2023.03.393

Article  PubMed  Google Scholar 

Sotomi Y, Hikoso S, Nakatani D et al (2021) Sex differences in heart failure with preserved ejection fraction. J Am Heart Assoc 10:1–20. https://doi.org/10.1161/JAHA.120.018574

Article  Google Scholar 

Benjamin EJ, Blaha MJ, Chiuve SE et al (2017) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e146–e603. https://doi.org/10.1161/CIR.0000000000000485

Article  PubMed  PubMed Central  Google Scholar 

Day S (2018) Heart failure with preserved ejection fraction. Encyclopedia of Cardiovascular Research and Medicine 1–4:464–468. https://doi.org/10.1016/B978-0-12-809657-4.10904-4

Article  Google Scholar 

Yang E, Vaishnav J, Song E et al (2022) Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction. ESC Heart Fail 9:2918. https://doi.org/10.1002/EHF2.13836

Article  PubMed  PubMed Central  Google Scholar 

Trevisan L, Cautela J, Resseguier N et al (2018) Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: a systematic angiography approach. Arch Cardiovasc Dis 111:109–118. https://doi.org/10.1016/J.ACVD.2017.05.006

Article  PubMed  Google Scholar 

Deney A, Nader V, Matta A et al (2022) Retrospective study of 573 patients with heart failure evaluated for coronary artery disease at Toulouse University Center, France. Med Sci Monit 28:e934804–1. https://doi.org/10.12659/MSM.934804

Brittain EL, Thenappan T, Huston JH et al (2022) Elucidating the clinical implications and pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction: a call to action: a scientific statement from the American Heart Association. Circulation 146:e73. https://doi.org/10.1161/CIR.0000000000001079

Article  PubMed  PubMed Central  Google Scholar 

Pulmonary hypertension in women - Brigham and Women’s Hospital. https://www.brighamandwomens.org/medicine/pulmonary-and-critical-care-medicine/womens-lung-health/pulmonary-hypertension-in-women. Accessed 25 Sep 2023

Daubert MA, Douglas PS (2019) Primary prevention of heart failure in women. JACC Heart Fail 7:181–191. https://doi.org/10.1016/J.JCHF.2019.01.011

Article  PubMed  Google Scholar 

Delicce AV, Makaryus AN (2023) Physiology, Frank Starling Law. StatPearls

Tadic M, Cuspidi C, Plein S et al (2019) Sex and heart failure with preserved ejection fraction: from pathophysiology to clinical studies. J Clin Med 8. https://doi.org/10.3390/JCM8060792

Arendse LB, Jan Danser AH, Poglitsch M et al (2019) Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev 71:539. https://doi.org/10.1124/PR.118.017129

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanna P, Shivkumar K, Ardell JL (2018) Calming the nervous heart: autonomic therapies in heart failure. Card Fail Rev 4:92. https://doi.org/10.15420/CFR.2018.20.2

Li S, Gupte AA (2017) The role of estrogen in cardiac metabolism and diastolic function. Methodist Debakey Cardiovasc J 13:4. https://doi.org/10.14797/MDCJ-13-1-4

Ueda K, Fukuma N, Adachi Y et al (2021) Sex differences and regulatory actions of estrogen in cardiovascular system. Front Physiol 12:738218. https://doi.org/10.3389/FPHYS.2021.738218/BIBTEX

Article  PubMed  PubMed Central  Google Scholar 

Parrish JN, Bertholomey ML, Pang HW et al (2019) Estradiol modulation of the renin–angiotensin system and the regulation of fear extinction. Transl Psychiatry 9. https://doi.org/10.1038/S41398-019-0374-0

Chen Y, Zhang Z, Hu F et al (2015) 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation. J Steroid Biochem Mol Biol 147:92–102. https://doi.org/10.1016/J.JSBMB.2014.12.011

Article  CAS  PubMed  Google Scholar 

Mori T, Kai H, Kajimoto H et al (2011) Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women. Hypertens Res 34:496–502. https://doi.org/10.1038/HR.2010.261

Article  CAS  PubMed  Google Scholar 

Subramanya V, Zhao D, Ouyang P et al (2018) Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the multi-ethnic study of atherosclerosis (MESA). Maturitas 108:37. https://doi.org/10.1016/J.MATURITAS.2017.11.006

Article  CAS  PubMed  Google Scholar 

Schafstedde M, Nordmeyer S (2023) The role of androgens in pressure overload myocardial hypertrophy. Front Endocrinol (Lausanne) 14. https://doi.org/10.3389/FENDO.2023.1112892

Szadkowska I, Guligowska A, Jegier A et al (2023) Serum testosterone level correlates with left ventricular hypertrophy in older women. Front Endocrinol (Lausanne) 13:1079043. https://doi.org/10.3389/FENDO.2022.1079043/BIBTEX

Article  PubMed  Google Scholar 

Xing C, Zhang J, Zhao H, He B (2022) Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment. Int J Womens Health 14:91–105. https://doi.org/10.2147/IJWH.S344542

Dos Santos RL, Da Silva FB, Ribeiro RF, Stefanon I (2014) Sex hormones in the cardiovascular system. Horm Mol Biol Clin Investig 18:89–103. https://doi.org/10.1515/HMBCI-2013-0048/ASSET/GRAPHIC/HMBCI-2013-0048_FIG2.JPG

Article  PubMed  Google Scholar 

Thomas P, Pang Y (2013) Protective actions of progesterone in the cardiovascular system: Potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids 78:583–588. https://doi.org/10.1016/J.STEROIDS.2013.01.003

Article  CAS  PubMed  Google Scholar 

Szmuilowicz ED, Adler GK, Ricchiuti V et al (2007) Relationships between endogenous sex hormone concentrations and vascular function in postmenopausal women. J Clin Endocrinol Metab 92:4738–4741. https://doi.org/10.1210/JC.2007-1471

Article  CAS  PubMed  Google Scholar 

Bhullar SK, Shah AK, Dhalla NS (2021) Role of angiotensin II in the development of subcellular remodeling in heart failure. Explor Med 2:352–371. https://doi.org/10.37349/EMED.2021.00054

Florijn BW, Bijkerk R, Van Der Veer EP, Van Zonneveld AJ (2018) Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? Cardiovasc Res 114:210–225. https://doi.org/10.1093/CVR/CVX223

Article  CAS  PubMed  Google Scholar 

Bernardo BC, Ooi JYY, Matsumoto A et al (2016) Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs. J Physiol 594:5959–5974. https://doi.org/10.1113/JP272512

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernández-Atucha A, Izagirre A, Fraile-Bermúdez AB et al (2017) Sex differences in the aging pattern of renin–angiotensin system serum peptidases. Biol Sex Differ 8. https://doi.org/10.1186/S13293-017-0128-8

Toering TJ, Gant CM, Visser FW et al (2018) Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects. Am J Physiol Renal Physiol 314:F873–F878. https://doi.org/10.1152/AJPRENAL.00109.2017

Article  CAS  PubMed  Google Scholar 

Tadic M, Cuspidi C, Frydas A, Grassi G (2018) The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? Heart Fail Rev 23:631–639. https://doi.org/10.1007/S10741-018-9698-8

Article  PubMed  Google Scholar 

Tadic M, Cuspidi C (2019) Obesity and heart failure with preserved ejection fraction: a paradox or something else? Heart Fail Rev 24:379–385. https://doi.org/10.1007/S10741-018-09766-X

Article  PubMed  Google Scholar 

McHugh K, DeVore AD, Wu J et al (2019) Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review. J Am Coll Cardiol 73:602–611. https://doi.org/10.1016/J.JACC.2018.11.033

Article  PubMed  Google Scholar 

Grassi G, Seravalle G, Quarti-Trevano F et al (2009) Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction. Hypertension 53:205–209. https://doi.org/10.1161/HYPERTENSIONAHA.108.121467

Article  CAS  PubMed  Google Scholar 

Zhou D, Yan M, Cheng Q et al (2022) Prevalence and prognosis of left ventricular diastolic dysfunction in community hypertension patients. BMC Cardiovasc Disord 22. https://doi.org/10.1186/S12872-022-02709-3

Rivera FB, Tang VAS, De Luna DV et al (2023) Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: a systematic review and meta-analysis. American Heart Journal Plus: Cardiology Research and Practice 26:100261. https://doi.org/10.1016/J.AHJO.2023.100261

Article  PubMed  Google Scholar 

Sharma A, Wood S, Bell JS et al (2023) Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: a population-based cohort study. Lancet Reg Health West Pac 33. https://doi.org/10.1016/j.lanwpc.2023.100692

Wang N, Evans J, Sawant S et al (2023) Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients. Heart Fail Rev 28:949–959. https://doi.org/10.1007/S10741-022-10275-1/FIGURES/3

Article  PubMed  Google Scholar 

Moss ME, Carvajal B, Jaffe IZ (2019) The endothelial mineralocorticoid receptor: contributions to sex differences in cardiovascular disease. Pharmacol Ther 203:107387. https://doi.org/10.1016/J.PHARMTHERA.2019.06.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniel KR, Wells G, Stewart K et al (2009) Effect of aldosterone antagonism on exercise tolerance, doppler diastolic function, and quality of life in older women with diastolic heart failure. Congest Heart Fail 15:68. https://doi.org/10.1111/J.1751-7133.2009.00056.X

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kosmala W, Rojek A, Przewlocka-Kosmala M et al (2016) Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68:1823–1834. https://doi.org/10.1016/J.JACC.2016.07.763

Article  CAS